REGN - CIK 0000872589
REGENERON PHARMACEUTICALS, INC. has filed 985 documents with the SEC between 2017 and 2026. The most frequent type is insider trade (631 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Insider trade | 4 | 2025-11-24 | 2025-11-20 |
| Insider sale notice | 144 | 2025-11-20 | - |
| Insider trade | 4 | 2025-11-10 | 2025-11-07 |
| Insider sale notice | 144 | 2025-11-07 | - |
| Institutional holdings | 13F-HR | 2025-11-07 | 2025-09-30 |
| Insider trade | 4 | 2025-10-31 | 2025-10-29 |
| Insider trade | 4 | 2025-10-31 | 2025-10-29 |
| Insider sale notice | 144 | 2025-10-29 | - |
| Quarterly report | 10-Q | 2025-10-28 | 2025-09-30 |
| Major company event | 8-K | 2025-10-28 | 2025-10-28 |
| Major company event | 8-K | 2025-10-06 | 2025-10-06 |
| SCHEDULE 13G/A | - | 2025-08-06 | - |
| Institutional holdings | 13F-HR | 2025-08-01 | 2025-06-30 |
| Quarterly report | 10-Q | 2025-08-01 | 2025-06-30 |
| Major company event | 8-K | 2025-08-01 | 2025-08-01 |
| Major company event | 8-K | 2025-06-18 | 2025-06-13 |
| Institutional holdings | 13F-HR | 2025-05-02 | 2025-03-31 |
| Quarterly report | 10-Q | 2025-04-29 | 2025-03-31 |
| Major company event | 8-K | 2025-04-29 | 2025-04-29 |
| Proxy materials | DEFA14A | 2025-04-29 | - |
| Proxy statement | DEF 14A | 2025-04-29 | 2025-06-13 |
| Annual report to shareholders | ARS | 2025-04-29 | 2024-12-31 |
| SCHEDULE 13G/A | - | 2025-04-22 | - |
| SEC correspondence | UPLOAD | 2025-04-17 | - |
| PRE 14A | - | 2025-04-07 | 2025-06-13 |
| Company correspondence | CORRESP | 2025-04-03 | - |
| SEC correspondence | UPLOAD | 2025-03-21 | - |
| SCHEDULE 13G/A | - | 2025-02-12 | - |
| Institutional holdings | 13F-HR | 2025-02-07 | 2024-12-31 |
| Annual report | 10-K | 2025-02-05 | 2024-12-31 |
| Major company event | 8-K | 2025-02-04 | 2025-02-04 |
| Major company event | 8-K | 2025-01-13 | 2025-01-13 |
| Insider trade | 4 | 2025-01-06 | 2025-01-02 |
| Insider trade | 4 | 2025-01-06 | 2025-01-02 |
| Insider trade | 4 | 2025-01-06 | 2025-01-02 |
| Insider trade | 4 | 2025-01-06 | 2025-01-02 |
| Insider trade | 4 | 2025-01-06 | 2025-01-02 |
| Insider trade | 4 | 2025-01-06 | 2025-01-02 |
| Insider trade | 4 | 2025-01-06 | 2025-01-02 |
| Insider trade | 4 | 2025-01-06 | 2025-01-02 |
| Insider trade | 4 | 2025-01-06 | 2025-01-02 |
| Insider trade | 4 | 2025-01-06 | 2025-01-02 |
| Insider trade | 4 | 2025-01-03 | 2024-12-31 |
| Insider trade | 4 | 2024-12-18 | 2024-12-16 |
| Insider trade | 4 | 2024-12-18 | 2024-12-16 |
| Insider trade | 4 | 2024-12-18 | 2024-12-16 |
| Insider trade | 4 | 2024-12-18 | 2024-12-16 |
| Insider trade | 4 | 2024-12-18 | 2024-12-16 |
| Insider trade | 4 | 2024-12-18 | 2024-12-16 |
| Insider trade | 4 | 2024-12-18 | 2024-12-16 |